Latest News & Features
Americas
Biotech fails to convince Federal Circuit to overturn PTAB finding | Invalidation of patent related to “Non-liposomal systems for nucleic acid delivery”. 12 April 2023
Americas
Feud concerned the ownership of six immunotherapy patents |
Cancer centre claimed that it was unfairly deprived of royalties. 11 April 2023
Big Pharma
Dispute stems from the theft of a data set of ZipCode sequences used in genetic testing | Plaintiff holds that pharma companies conspired against him |
Cornell University claimed Thermo Fisher had misled it into settling a lawsuit in 2017. 11 April 2023
Big Pharma
Feud involved a blockbuster cancer drug belonging to a family of PARP inhibitors | GSK unit failed to persuade the court of the merits of its ‘certain uses’ argument. 6 April 2023
Biotechnology
Arbutus and Genevant claims Pfizer/BioNTech vaccine uses patented technology | Claim follows last year’s lawsuit against Moderna. 6 April 2023
Generics
Lawsuit is second to be filed in Delaware over Abbvie’s Orilissa treatment | Abbive says Teva’s ANDA infringes patent granted in January. 4 April 2023
Americas
Pinsent Masons and Sterne, Kessler, Goldstein, & Fox consider why the Unified Patent Court, due to open on June 1, 2023, will make Europe a more attractive patent litigation venue for US businesses. 4 April 2023
Big Pharma
The three companies will make low-cost versions of HIV PrEP drug | Generics will be available to consumers in 90 low- and middle-income countries. 30 March 2023
Americas
H&H Wholesale Services found to have committed ‘fraud on the court’ | Final amount includes attorneys’ fees and costs. 30 March 2023
Americas
As the US Supreme Court probed the key issue of enablement in Amgen v Sanofi, patent lawyers shared their views on the much-anticipated hearings. 28 March 2023